Abstract
Drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) are a target for new antimicrobial technologies. Far-UVC technology is an emerging disinfection method that directly kills microorganisms using light. In contrast with conventional UV sterilization, far-UVC light has antimicrobial capabilities without apparent harm to mammalian cells. This study examines the application of 224 nm far-UVC light delivered from a laser using an optical diffuser towards the goal of protecting against bacterial invasion around skin penetrating devices. Delivery of far-UVC using a laser and optical fibers enables exposure to unique geometries that would otherwise be shielded when using a lamp. Testing of the bactericidal potential of diffusing the far-UVC laser output over a large area was tested and yielded qualitative area killing results. The killing of MRSA using this method was also examined using an in vitro survival assay. Results followed a classic log-linear disinfection model with a rate constant of k = 0.51 cm2/mJ, which corresponds to an inactivation cross section of D90 = 4.5 mJ/cm2. This study establishes far-UVC delivered from a laser through an optical diffuser as a viable solution for disinfection of susceptible regions such as around catheters, drivelines, or other skin penetrating medical devices.
Highlights
Infections from drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) present major health care challenges with over 23,000 cases resulting in death in the United States each year [1]
This study examines the use of far-UVC light generated from a laser source to be delivered via fiber optics to an optical diffuser element for bactericidal applications
An unmodified picture of the bacteria plate is shown in the inset of the figure
Summary
Infections from drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) present major health care challenges with over 23,000 cases resulting in death in the United States each year [1]. Fighting these infections is a strain on limited healthcare resources considering the average length of a hospital stay is estimated at more than 11 days longer for infected individuals than those without infection [2]. While significant resources have been applied to combat infection from drug-resistant bacteria, and incremental gains have been reported, effective resolutions remain elusive.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.